20200120163240asfjn3
20200120163240asfjn3

Gadoterate Meglumine

Product：Gadoterate Meglumine
Indication：Gadolinium-based MRI contrast agent
Specification：In-house
Regulatory status：US, China, Taiwan
 
BACK BACK